Cervical Cancer: Clinical Trials

1,317 trials for Cervical Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

540 completed, 285 unknown, 217 recruiting, 89 terminated. 426 Not applicable, 324 Phase 2, 199 Phase 1, 111 Phase 3, 30 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable426Completed 206, Unknown 87, Recruiting 75, Active not recruiting 20, Not yet recruiting 17, Terminated 13, Withdrawn 5, Enrolling by invitation 3
Phase 2324Completed 105, Recruiting 61, Unknown 59, Terminated 40, Active not recruiting 21, Not yet recruiting 21, Withdrawn 16, Enrolling by invitation 1
Phase 1199Completed 70, Recruiting 36, Terminated 33, Unknown 25, Active not recruiting 19, Withdrawn 11, Not yet recruiting 3, Enrolling by invitation 1, Suspended 1
Phase 3111Completed 45, Unknown 24, Recruiting 17, Active not recruiting 8, Terminated 8, Not yet recruiting 4, Withdrawn 3, Enrolling by invitation 1, Suspended 1
Phase 430Completed 15, Unknown 8, Recruiting 3, Not yet recruiting 2, Terminated 2
Early Phase 18Completed 4, Unknown 3, Active not recruiting 1

Follow Cervical Cancer: new trials by email Literature Review of Cervical Cancer trials Research Report on Cervical Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC)
DOSE-CC Intervention: Educational Sessions - Cervical Cancer Screening, Cervical Cancer
Not applicableNot yet recruitingBoston Medical Center800002027-05-012026-10-30
My Self-Sampling for HPV Awareness, Results, and Empowerment
MySHARE+ mHealth Education Intervention, Healthcare Provider Prompt - Cervical Cancer, Cervical Cancer Screening
Not applicableNot yet recruitingDaisy Le1302027-01-012026-08-18
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Telaglenastat, Radiation treatment, Cisplatin - Advanced Cervical Carcinoma, Cervical Cancer
Phase 2Not yet recruitingWashington University School of Medicine422026-12-312026-09-03
Vaginal Dose De-escalation During Brachytherapy for Cervical Cancer
radiation dose de-escalation - Cervical Cancer
Not applicableNot yet recruitingDuke University202026-12-012026-10-02
COQ10 and Vitamin E for Off-Target Radiation Toxicity
Coenzyme Q10 Cap/Tab, Vitamin E Cap/Tab - Prostate Cancer, Uterine Cancer
Phase 1 / Phase 2Not yet recruitingUniversity of Nebraska2002026-12-012026-10-08
Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing
Web-Based Health Education - Cervical Cancer, HPV
Not applicableNot yet recruitingSakarya University1202026-12-012026-11-16
Ultrashort Echo Time (UTE) MRI for Applicator Reconstruction in Gynaecologic Cancer Brachytherapy
Ultrashort Echo Time (UTE) MRI - Cervical Cancer, Endometrium Cancer
Not applicableNot yet recruitingMahidol University502026-12-012026-11-16
Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers
sample collection - Non Small Cell Lung Cancer, Melanoma (Skin Cancer)
Not applicableNot yet recruitingEuropean Institute of Oncology3602026-11-112026-11-04
C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States
Qualitative interviews, Focus groups - Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV)
Not yet recruitingUNC Lineberger Comprehensive Cancer Center35002026-11-102026-10-20
C2001P-CS3: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
HPV DNA Testing (Abbott Alinity m HPV Assay), Visual Inspection with Acetic Acid, Cervical Histology (Biopsy Procedures) - Human Papillomavirus (HPV), HPV Associated Cancers
Not applicableRecruitingUniversity of California, San Diego7502026-11-092026-11-12
Tucatinib Continuation Study
tucatinib - HER2-positive Breast Cancer, Cervical Cancer
Phase 4Not yet recruitingPfizer1752026-11-062026-08-28
Breast and Cervical Cancer Stigma in Rwanda
Behavioral: RISE Intervention, Behavioral: CHW Educational Intervention - Breast Cancer, Cervical Cancer
Not applicableNot yet recruitingDana-Farber Cancer Institute11162026-11-012026-06-23
Adaptive Radiotherapy for Safe Hypofractionation
Adaptive Hypofractionated Radiotherapy, Standard-of-care Radiotherapy - Cancer, Endometrial Cancer
Phase 2Not yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)2642026-11-012026-10-29
Inactivated KAWAI Bacteria for Diarrhea Prevention During Pelvic Radiotherapy in Postoperative Cervical Cancer
KAWAI powder, Placebo - Cervical Cancer
Not applicableNot yet recruitingObstetrics & Gynecology Hospital of Fudan University1002026-10-282026-10-28
C2001P-CS6: Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
HPV DNA Testing (Abbott Alinity m HPV Assay), Visual Inspection with Acetic Acid, Cervical Histology (Biopsy Procedures) - Human Papillomavirus (HPV), HPV Associated Cancers
Not applicableRecruitingUniversity of California, San Diego7502026-10-162026-11-09
Hydrogel Spacer During Definitive Radiotherapy for Cervical Cancer
Absorbable Hydrogel Spacer - Cervical Cancer
Not applicableRecruitingTianjin Medical University Cancer Institute and Hospital302026-10-122026-10-29
Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions
Routine-care metastasis-directed radiotherapy - Cervical Cancer, Gynecologic Cancer
RecruitingAffidea Nu-med Center of Oncological DIagnostics and Therapy5002026-10-062026-10-23
Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic Surgery
DEX 0.2 μg/kg/h., SGB, 0.9% Sodium Chloride (Placebo) - Uterine Fibroids (Leiomyoma), Adenomyosis of Uterus
Not applicableRecruitingCatherin Zhang1002026-10-012026-10-06
PEG-rhG-CSF Primary Prophylaxis vs Therapeutic Short-Acting rhG-CSF for Neutropenia During Pelvic Chemoradiotherapy in Cervical or Endometrial Cancer
Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor (PEG-rhG-CSF), Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) - Cervical Cancer, Endometrial Cancer
Not applicableActive not recruitingThe Second Hospital of Anhui Medical University902026-09-152026-10-08
Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)
Stereotactic Body Radiation Therapy (SBRT), Pembrolizumab, Nivolumab - Head and Neck Cancer, Non-Small Cell Lung Cancer
Phase 2RecruitingMark Bernard352026-09-092026-10-14

Showing 20 of 1317. Sign in to see all of them.

Narrower conditions

Uterine Cervical Neoplasms (1317)  ·  Ovarian Neoplasms (182)  ·  Endometrial Neoplasms (170)  ·  Breast Neoplasms (118)  ·  Uterine Cervical Dysplasia (114)  ·  Carcinoma, Non-Small-Cell Lung (85)  ·  Papillomavirus Infections (80)  ·  Stomach Neoplasms (73)  ·  Colorectal Neoplasms (72)  ·  Vulvar Neoplasms (70)  ·  Esophageal Neoplasms (64)  ·  Vaginal Neoplasms (63)  ·  Lung Neoplasms (62)  ·  Uterine Neoplasms (59)  ·  Melanoma (58)

Broader conditions

Genital Diseases (1317)  ·  Female Urogenital Diseases (1316)  ·  Female Urogenital Diseases and Pregnancy Complications (1316)  ·  Urogenital Diseases (1316)  ·  Urogenital Neoplasms (1314)  ·  Neoplasms by Site (1313)  ·  Genital Diseases, Female (1312)  ·  Genital Neoplasms, Female (1312)  ·  Uterine Diseases (1312)  ·  Uterine Cervical Diseases (1308)  ·  Neoplasms (1260)  ·  Uterine Neoplasms (1258)  ·  Pathological Conditions, Signs and Symptoms (214)  ·  Endocrine Gland Neoplasms (213)  ·  Endocrine System Diseases (213)

Interventions

Cisplatin (111)  ·  Radiotherapy (51)  ·  Paclitaxel (50)  ·  Carboplatin (46)  ·  pembrolizumab (45)  ·  Brachytherapy (41)  ·  Bevacizumab (27)  ·  Surveys and Questionnaires (24)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (22)  ·  Topotecan (16)  ·  Blood Specimen Collection (14)  ·  atezolizumab (14)  ·  Colposcopy (13)  ·  Docetaxel (13)  ·  Drug Therapy (12)

Sponsors

M.D. Anderson Cancer Center (36)  ·  Gynecologic Oncology Group (25)  ·  National Cancer Institute (NCI) (24)  ·  Merck Sharp & Dohme LLC (19)  ·  Huazhong University of Science and Technology (15)  ·  Memorial Sloan Kettering Cancer Center (15)  ·  Peking Union Medical College Hospital (15)  ·  Duke University (14)  ·  National Taiwan University Hospital (13)  ·  Sun Yat-sen University (11)  ·  Washington University School of Medicine (11)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (10)  ·  Tata Memorial Hospital (10)  ·  UNC Lineberger Comprehensive Cancer Center (10)  ·  Xiamen University (10)

Countries

United States (471)  ·  China (263)  ·  Canada (71)  ·  France (70)  ·  United Kingdom (55)  ·  South Korea (54)  ·  Italy (48)  ·  Spain (42)  ·  Taiwan (42)  ·  Belgium (36)  ·  Germany (34)  ·  Australia (33)  ·  Netherlands (31)  ·  India (29)  ·  Brazil (23)

Top investigators

Michele Follen, MD, PhD (7)  ·  Kathleen Schmeler, MD (6)  ·  Ting Wu, Ph. D. (6)  ·  Chi-An Chen, MD (5)  ·  Ding Ma, MD, PhD (5)  ·  Lei Li, M.D. (5)  ·  Brigitte E. Miller, MD (4)  ·  Ding Ma (4)  ·  Dongling Zou, M.D. (4)  ·  Jun Zhang, Master (4)  ·  Jun Zhang, master (4)

Results publications

PMID 41276263, PMID 19236277, PMID 19236279, PMID 19935017, PMID 30380365, PMID 30982556, PMID 32184277, PMID 32779730, PMID 37650664, PMID 41166720, PMID 20949623, PMID 21471141, PMID 22454089, PMID 23066159, PMID 23299013, PMID 23632723, PMID 25071111, PMID 26348120, PMID 26438146, PMID 27432417, PMID 29074187, PMID 29995724, PMID 33326342, PMID 38416430, PMID 42580817, PMID 11224527, PMID 11230468, PMID 11901547, PMID 11919208, PMID 12011138, PMID 12713990, PMID 12821360, PMID 14615449, PMID 14766258, PMID 14984966, PMID 15047228, PMID 15050330, PMID 15240681, PMID 15310778, PMID 15589587, PMID 15712779, PMID 15805295, PMID 15863167, PMID 15911864, PMID 15911865, PMID 16110319, PMID 16150255, PMID 16216315, PMID 16230678, PMID 16234512

NIH funding

2023 (9), 2019 (7), 2018 (6), P01CA082710 (4), P30CA016672 (4), P30CA043703 (4), U24CA275417 (4), 2015 (3), 2017 (3), UG1CA275414 (3), 2008 (2), 2009 (2), 2016 (2), 2025 (2), P30CA015704 (2)